
DexCom DXCM
$ 79.02
-1.46%
DexCom Operating Cycle | DXCM
Annual Operating Cycle DexCom
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 202 | 216 | 204 | 195 | 211 | 168 | 151 | 150 | 141 | 150 | 171 | 130 | 114 | 122 | 134 | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 216 | 114 | 164 |
Quarterly Operating Cycle DexCom
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 225 | 217 | 225 | 205 | 205 | 207 | 205 | 195 | 221 | 227 | 243 | 205 | 191 | 183 | 193 | 174 | 174 | 199 | 215 | 211 | 222 | 227 | 227 | 181 | 165 | 144 | 146 | 123 | 125 | 134 | 140 | 103 | 104 | 104 | 131 | 50.5 | 52.5 | 50.2 | 60.1 | 47.6 | 46.2 | 46.9 | 55.5 | 128 | 144 | 141 | 133 | 78.5 | 54.2 | 49.5 | 72.5 | 72.3 | 51.6 | 48.6 | 82 | 69 | 45.1 | 57.7 | 97.6 | 82.6 | 57.5 | 69 | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 243 | 45.1 | 135 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | ||
|
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | ||
|
National Research Corporation
NRC
|
33.4 | $ 25.18 | 0.76 % | $ 564 M | ||
|
Twist Bioscience Corporation
TWST
|
113 | $ 103.2 | -7.54 % | $ 6.46 B | ||
|
Organovo Holdings
ONVO
|
18.4 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
1.68 | - | -16.95 % | $ 1.54 M | ||
|
PerkinElmer
PKI
|
179 | - | -0.91 % | $ 14.7 B | ||
|
Soleno Therapeutics
SLNO
|
193 | - | - | $ 2.69 B | ||
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
Renalytix AI plc
RNLX
|
15.9 | - | 5.66 % | $ 22.7 M | ||
|
Meridian Bioscience
VIVO
|
238 | - | - | $ 1.49 B | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | ||
|
T2 Biosystems
TTOO
|
131 | - | -39.35 % | $ 313 K | ||
|
Syneos Health
SYNH
|
32.3 | - | - | $ 4.46 B | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
Invitae Corporation
NVTA
|
368 | - | - | $ 21.2 M | ||
|
Quotient Limited
QTNT
|
396 | - | -11.32 % | $ 1.1 M | ||
|
Burning Rock Biotech Limited
BNR
|
245 | $ 13.46 | 1.05 % | $ 142 M | ||
|
Medpace Holdings
MEDP
|
50.4 | $ 609.81 | -3.81 % | $ 17.6 B | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
Surmodics
SRDX
|
201 | - | - | $ 608 M | ||
|
RadNet
RDNT
|
49.3 | $ 69.77 | 0.37 % | $ 5.25 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Psychemedics Corporation
PMD
|
57.4 | - | -1.84 % | $ 15.3 M | ||
|
IDEXX Laboratories
IDXX
|
128 | $ 675.24 | -2.09 % | $ 54.3 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Biodesix
BDSX
|
36.4 | $ 7.55 | -9.1 % | $ 57 M | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | ||
|
Agilent Technologies
A
|
184 | $ 169.82 | -3.21 % | $ 48.2 B | ||
|
Charles River Laboratories International
CRL
|
107 | $ 314.38 | -4.13 % | $ 15.6 B | ||
|
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 257.78 | -0.4 % | $ 28.6 B | ||
|
Danaher Corporation
DHR
|
143 | $ 220.3 | -3.19 % | $ 157 B | ||
|
Anixa Biosciences
ANIX
|
385 | $ 2.44 | -6.15 % | $ 79.2 K | ||
|
Guardant Health
GH
|
128 | $ 145.9 | 0.21 % | $ 18.3 B | ||
|
BioNano Genomics
BNGO
|
315 | $ 0.82 | -7.56 % | $ 4.46 M | ||
|
Bioventus
BVS
|
259 | $ 9.89 | -0.65 % | $ 659 M | ||
|
IQVIA Holdings
IQV
|
86.8 | $ 245.67 | -1.92 % | $ 42.2 B | ||
|
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 367.68 | -0.44 % | $ 30.6 B | ||
|
Castle Biosciences
CSTL
|
97.4 | $ 32.69 | -2.14 % | $ 948 M | ||
|
Mettler-Toledo International
MTD
|
148 | $ 1 667.59 | -2.3 % | $ 34.4 B | ||
|
Illumina
ILMN
|
204 | $ 192.79 | -3.92 % | $ 29.9 B | ||
|
Natera
NTRA
|
90.2 | $ 273.11 | -5.8 % | $ 37.3 B | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 28.63 | -2.22 % | $ 27.1 B |